About Prostatic acid phosphatase
Prostatic acid phosphatase (ACP3) is a protein
from Homo sapiens identified by UniProt accession
P15309, 386 residues long.
MolForge cross-references it against 0 known binders and
194 disease associations.
Target properties
| Protein name | Prostatic acid phosphatase |
| UniProt accession | P15309 |
| Gene | ACP3 |
| Organism | Homo sapiens |
| Length | 386 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (194)
Diseases linked to this target (Open Targets).
- prostate cancer · score 0.50
- neoplasm · score 0.40
- hematocrit · score 0.37
- self reported educational attainment · score 0.33
- serum albumin measurement · score 0.31
- Red cell distribution width · score 0.31
- prostate adenocarcinoma · score 0.30
- hemoglobin measurement · score 0.23
- creatinine measurement · score 0.16
- total cholesterol measurement · score 0.16
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P15309-F1 | alphafold | PREDICTED | 92.24 | — |
Amino-acid sequence (386 residues)
MRAAPLLLAR AASLSLGFLF LLFFWLDRSV LAKELKFVTL VFRHGDRSPI DTFPTDPIKE SSWPQGFGQL TQLGMEQHYE LGEYIRKRYR KFLNESYKHE QVYIRSTDVD RTLMSAMTNL AALFPPEGVS IWNPILLWQP IPVHTVPLSE DQLLYLPFRN CPRFQELESE TLKSEEFQKR LHPYKDFIAT LGKLSGLHGQ DLFGIWSKVY DPLYCESVHN FTLPSWATED TMTKLRELSE LSLLSLYGIH KQKEKSRLQG GVLVNEILNH MKRATQIPSY KKLIMYSAHD TTVSGLQMAL DVYNGLLPPY ASCHLTELYF EKGEYFVEMY YRNETQHEPY PLMLPGCSPS CPLERFAELV GPVIPQDWST ECMTTNSHQG TEDSTD
Explore Prostatic acid phosphatase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets